rabeprazole has been researched along with Gastritis, Atrophic in 5 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Gastritis, Atrophic: GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with early gastric cancers that are limited to gastric mucosa or submucosa usually have an advanced loss of mucosal glandular tissue (glandular atrophy) and are at high risk for subsequent (metachronous) development of new gastric cancer." | 2.87 | Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. ( Cho, SJ; Choi, IJ; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Nam, BH; Park, B, 2018) |
"This study aimed to investigate the application and effectiveness of Morodan combined with rabeprazole in patients with chronic gastritis, focusing on its impact on gastric mucosa repair." | 1.91 | The Efficacy of Morodan in Combination with Rabeprazole for the Treatment of Chronic Gastritis and its Impact on Gastric Mucosal Repair. ( Guo, R; Li, Y; Ma, Q; Ma, S, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Ma, S | 1 |
Li, Y | 1 |
Guo, R | 1 |
Ma, Q | 1 |
Kodama, M | 1 |
Okimoto, T | 1 |
Mizukami, K | 1 |
Hirashita, Y | 1 |
Wada, Y | 1 |
Fukuda, M | 1 |
Matsunari, O | 1 |
Okamoto, K | 1 |
Ogawa, R | 1 |
Fukuda, K | 1 |
Kudo, Y | 1 |
Kawahara, Y | 1 |
Murakami, K | 1 |
Choi, IJ | 1 |
Kook, MC | 1 |
Kim, YI | 1 |
Cho, SJ | 1 |
Lee, JY | 1 |
Kim, CG | 1 |
Park, B | 1 |
Nam, BH | 1 |
Mitsui, Y | 1 |
Kagemoto, K | 1 |
Itagaki, T | 1 |
Inoue, S | 1 |
Naruse, K | 1 |
Muguruma, N | 1 |
Takayama, T | 1 |
Fujiwara, S | 1 |
Morita, Y | 1 |
Toyonaga, T | 1 |
Kawakami, F | 1 |
Itoh, T | 1 |
Yoshida, M | 1 |
Kutsumi, H | 1 |
Azuma, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer[NCT02407119] | Phase 3 | 470 participants (Actual) | Interventional | 2003-06-30 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for rabeprazole and Gastritis, Atrophic
Article | Year |
---|---|
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug | 2018 |
A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine; Anti-Ulcer Agents; Disease Progression; Drug | 2011 |
3 other studies available for rabeprazole and Gastritis, Atrophic
Article | Year |
---|---|
The Efficacy of Morodan in Combination with Rabeprazole for the Treatment of Chronic Gastritis and its Impact on Gastric Mucosal Repair.
Topics: Gastric Mucosa; Gastritis, Atrophic; Helicobacter pylori; Humans; Rabeprazole; Treatment Outcome | 2023 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; | 2021 |
Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy, Digestive System; Gastritis, Atrophic | 2015 |